Protagenic Therapeutics, Inc. – NASDAQ:PTIXW

Protagenic Therapeutics stock price today

$0.05
+0.04
+773.68%
Financial Health
0
1
2
3
4
5
6
7
8
9

Protagenic Therapeutics stock price monthly change

-25.93%
month

Protagenic Therapeutics stock price quarterly change

-25.93%
quarter

Protagenic Therapeutics stock price yearly change

-60.00%
year

Protagenic Therapeutics key metrics

Market Cap
4.36M
Enterprise value
280.59K
P/E
-0.02
EV/Sales
N/A
EV/EBITDA
-0.05
Price/Sales
N/A
Price/Book
0.02
PEG ratio
N/A
EPS
-1.37
Revenue
N/A
EBITDA
-5.31M
Income
-6.00M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Protagenic Therapeutics stock price history

Protagenic Therapeutics stock forecast

Protagenic Therapeutics financial statements

Protagenic Therapeutics, Inc. (NASDAQ:PTIXW): Profit margin
Jun 2023 0 -1.20M
Sep 2023 0 -1.39M
Dec 2023 3.2K -1.67M -52380.75%
Mar 2024 0 -1.72M
Protagenic Therapeutics, Inc. (NASDAQ:PTIXW): Debt to assets
Jun 2023 6919121 1.50M 21.76%
Sep 2023 5432642 1.28M 23.56%
Dec 2023 4323369 655.25K 15.16%
Mar 2024 2578558 446.09K 17.3%
Protagenic Therapeutics, Inc. (NASDAQ:PTIXW): Cash Flow
Jun 2023 -1.53M 1.61M 0
Sep 2023 -655.76K 590.72K -10
Dec 2023 -1.14M 2.27M 10
Mar 2024 -1.65M 1.20M 0

Protagenic Therapeutics alternative data

Protagenic Therapeutics, Inc. (NASDAQ:PTIXW): Employee count
Mar 2024 2
Apr 2024 2
May 2024 1
Jun 2024 1
Jul 2024 1

Protagenic Therapeutics other data

0.01% -0.04%
of PTIXW is owned by hedge funds
25K -176.16K
shares is hold by hedge funds

Protagenic Therapeutics, Inc. (NASDAQ:PTIXW): Insider trades (number of shares)
Period Buy Sel
Jun 2021 17000 0
May 2022 31000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
ARROW ALEXANDER K. officer: Chief Financial Officer
PTIX Common Stock 8,000 $0.72 $5,760
Purchase
ARROW ALEXANDER K. officer: Chief Financial Officer
PTIX Common Stock 23,000 $0.71 $16,330
Purchase
ARROW ALEXANDER K. officer: Chief Financial Officer
PTIXW Common Stock 5-year warrants strike price $4.98 16,900 $4.98 $84,162
Purchase
ARROW ALEXANDER K. officer: Chief Financial Officer
PTIXW Common Stock 5-year warrants strike price $4.98 100 $4.98 $498
Purchase
ARROW ALEXANDER K. officer: Chief Financial Officer
PTIXW Common Stock 5-year warrants strike price $4.98 3,000 $4.98 $14,940
Purchase
ARROW ALEXANDER K. officer: Chief Financial Officer
PTIXW Common Stock 5-year warrants strike price $4.98 18,000 $4.98 $89,640
Purchase
ARROW ALEXANDER K. officer: Chief Financial Officer
PTIXW Common Stock 5-year warrants strike price $4.98 12,000 $4.98 $59,760
Option
BARRAGE KHALIL director
PTIX Common stock Options 120,000 $1.75 $210,000
Option
BARRAGE KHALIL director
PTIX Common stock Options 45,000 $1.75 $78,750
Option
BARRAGE KHALIL director
PTIX Common stock Options 150,000 $1.25 $187,500
  • What's the price of Protagenic Therapeutics stock today?

    One share of Protagenic Therapeutics stock can currently be purchased for approximately $0.05.

  • When is Protagenic Therapeutics's next earnings date?

    Unfortunately, Protagenic Therapeutics's (PTIXW) next earnings date is currently unknown.

  • Does Protagenic Therapeutics pay dividends?

    No, Protagenic Therapeutics does not pay dividends.

  • How much money does Protagenic Therapeutics make?

    Protagenic Therapeutics has a market capitalization of 4.36M.

  • What is Protagenic Therapeutics's stock symbol?

    Protagenic Therapeutics, Inc. is traded on the NASDAQ under the ticker symbol "PTIXW".

  • What is Protagenic Therapeutics's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Protagenic Therapeutics?

    Shares of Protagenic Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Protagenic Therapeutics have?

    As Jul 2024, Protagenic Therapeutics employs 1 workers, which is 50% less then previous quarter.

  • When Protagenic Therapeutics went public?

    Protagenic Therapeutics, Inc. is publicly traded company for more then 4 years since IPO on 27 Apr 2021.

  • What is Protagenic Therapeutics's official website?

    The official website for Protagenic Therapeutics is protagenic.com.

  • Where are Protagenic Therapeutics's headquarters?

    Protagenic Therapeutics is headquartered at 149 Fifth Avenue, New York, NY.

  • How can i contact Protagenic Therapeutics?

    Protagenic Therapeutics's mailing address is 149 Fifth Avenue, New York, NY and company can be reached via phone at +212 9948200.

Protagenic Therapeutics company profile:

Protagenic Therapeutics, Inc.

protagenic.com
Exchange:

NASDAQ

Full time employees:

1

Industry:

Biotechnology

Sector:

Healthcare

Protagenic Therapeutics, Inc., a pre-clinical biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114 is a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company was founded in 2016 and is based in New York, New York.

149 Fifth Avenue
New York, NY 10010

CIK: 0001022899
ISIN: US74365N1110
CUSIP: 74365N111